Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.Considering these trends, value investing is clearly one of the most preferred ways to find strong stocks in any type of market. Value investors use fundamental analysis and traditional valuation metrics to find stocks that they believe are being un ...

Core Insights - Investors in the Business - Services sector should consider Concentrix Corporation (CNXC) and Thomson Reuters (TRI) for potential value opportunities [1] Valuation Metrics - CNXC has a forward P/E ratio of 4.14, significantly lower than TRI's forward P/E of 44.92 [5] - CNXC's PEG ratio is 0.57, while TRI's PEG ratio is 5.61, indicating CNXC is more favorably valued in terms of expected earnings growth [5] - CNXC's P/B ratio is 0.72 compared to TRI's P/B of 6.18, further suggesting CNXC is undervalued relative to its book value [6] Earnings Outlook - CNXC holds a Zacks Rank of 2 (Buy), indicating a positive earnings estimate revision trend, while TRI has a Zacks Rank of 3 (Hold) [3] - The stronger estimate revision activity for CNXC suggests a more favorable earnings outlook compared to TRI [7] Value Grades - CNXC has a Value grade of A, while TRI has a Value grade of F, highlighting CNXC's superior valuation metrics [6]

The proven Zacks Rank system focuses on earnings estimates and estimate revisions to find winning stocks. Nevertheless, we know that our readers all have their own perspectives, so we are always looking at the latest trends in value, growth, and momentum to find strong picks. Looking at the history of these trends, perhaps none is more beloved than value investing. This strategy simply looks to identify companies that are being undervalued by the broader market. Value investors use tried-and-true metrics an ...

Investors looking for stocks in the Medical Services sector might want to consider either Organon (OGN) or Medpace (MEDP) . But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look.There are plenty of strategies for discovering value stocks, but we have found that pairing a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system produces the best returns. The Zacks Rank is a proven strategy that targets compani ...

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.Of these, perhaps no stock market trend is more popular than value investing, which is a strategy that has proven to be successful in all sorts of market environments. Value investors use fundamental analysis and traditional valuation metrics to fin ...